Caregiver

Lunderg Launches Bed Alarm Technology, Redefines Elderly Patient Care

Retrieved on: 
Tuesday, April 2, 2024
Risk, Patient, Caregiver, Dignity, Accident, Health, Safety

Cheyenne, Wyoming--(Newsfile Corp. - April 2, 2024) - Medical equipment company Lunderg has launched its early-alert bed alarm technology, designed specifically to improve the response, care, and safety of elderly patients.

Key Points: 
  • Cheyenne, Wyoming--(Newsfile Corp. - April 2, 2024) - Medical equipment company Lunderg has launched its early-alert bed alarm technology, designed specifically to improve the response, care, and safety of elderly patients.
  • Lunderg's bed alarm technology comes at a crucial time, given the trend of leveraging technology to elevate patient care, the growing elderly population, and the increasing need for continuous monitoring of individuals with conditions predisposing them to accidents such as falls.
  • Shawn Higgins, the CEO of Lunderg, describes their bed alarm technology as a cutting-edge, under-mattress system designed to alert caregivers immediately when a patient attempts to leave their bed, chair, wheelchair, or sofa.
  • The bed alarm system is part of Lunderg's comprehensive Fall Prevention Products line, alongside its chair alarm systems, sensor pads, call buttons, bed rails, and more.

Agios Publishes 2024 Environmental, Social and Governance (ESG) Report

Retrieved on: 
Tuesday, April 9, 2024
Erg, Information technology, Caregiver, Health equity, Agios Pharmaceuticals, ESG, Patient, Female, Equity, AGIO, Social, Pharmaceutical industry

CAMBRIDGE, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the publication of its 2024 Environmental, Social and Governance Report, which provides corporate sustainability disclosures for the period Jan. 1, 2023 to Dec. 31, 2023.

Key Points: 
  • – Report Highlights Company’s Focus on Red Blood Cell Health; Diversity, Equity & Inclusion; and Strong Corporate Governance –
    CAMBRIDGE, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the publication of its 2024 Environmental, Social and Governance Report, which provides corporate sustainability disclosures for the period Jan. 1, 2023 to Dec. 31, 2023.
  • Our ESG report is a shining reflection of our ‘how’ and a testament to the important contributions made by every function at Agios,” said Brian Goff, chief executive officer of Agios.
  • Diversity at Agios: Representative, cognitive and experiential differences among team members are highly valued at Agios, and the company demonstrated tangible successes in 2023.
  • To learn more about ESG at Agios, read the full report here .

Is Sundown Syndrome Taking Over Your Evenings? Michele Nealon, Psy.D. Shares Expert Tips to Manage the Symptoms

Retrieved on: 
Tuesday, April 9, 2024
Health, Agitation, Sleep apnea, Alzheimer's disease, Confusion, Exercise, Chicago school, Hunger, Depression, Caregiver, Diabetes, Empathy, Stroke, Sleep, Mental health, Sundowning, Anxiety, Frustration, Dementia, Medicine, Residential care

Sundown syndrome is a state of confusion or agitation that comes on in the late afternoon and worsens into the night, preventing the person from getting sleep.

Key Points: 
  • Sundown syndrome is a state of confusion or agitation that comes on in the late afternoon and worsens into the night, preventing the person from getting sleep.
  • This syndrome's cause is not well understood, but we know it can take a toll on the individual and their caregivers.
  • Setting a schedule of regular exercise, a healthy diet, and quality sleep for you and the person you are taking care of is imperative.
  • Patience and empathy are key when trying to ease their agitation because it can worsen if they sense your frustration.

Creyos Health Announces Addition of Dementia Screening, Testing, and Care Planning to its Online Platform

Retrieved on: 
Tuesday, April 9, 2024
Western University, Diagnosis, AMGA, Research, Dementia, Prevalence, Entrepreneurship, Deficit spending, Disease, Caregiver, Patient, American Medical Group Association, OBE, Doctor of Philosophy, Statistics, MCI, Cognition

This protocol, now available in the Creyos platform, is the result of 30 years of rigorous research and scientific validation.

Key Points: 
  • This protocol, now available in the Creyos platform, is the result of 30 years of rigorous research and scientific validation.
  • It offers full spectrum cognitive care, from early detection of mild cognitive impairment, to testing for an accurate dementia diagnosis, followed by tailored care planning, and ongoing longitudinal monitoring.
  • Dementia testing includes four additional tasks and behavioral health questionnaires, aligned with DSM-5 diagnostic criteria for dementia.
  • “We started Creyos because we noticed a significant gap in how cognitive health was being addressed,” said Marc Lipton, Co-Founder and CEO of Creyos.

Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals

Retrieved on: 
Monday, April 8, 2024
SOC, CDMO, Orphan drug, Letter, Cell, Science, Bone marrow, Disease, Partnership, Caregiver, Hypoplastic left heart syndrome, Patient, Fast Track, Research, Microsoft Exchange Server, Standard of care, Security (finance), CLEAR, Surgeon, Regenerative medicine, FDA, BLA, Development, Pharmaceutical industry

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders.

Key Points: 
  • MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders.
  • Today, I am excited to update you on our overall strategy, business objectives, approach to capital allocation, and 2024 key priorities and goals.
  • Our focus remains steadfast on raising the funds necessary to continue our operations and delivering transformative solutions to patients and creating sustainable value for our shareholders.
  • In 2024, we are focusing our efforts on two of our most promising programs: Hypoplastic Left Heart Syndrome (HLHS); and Alzheimer’s Disease.

CURE Media Group and Oncology Nursing News announce Kristen Dahlgren as keynote speaker for the 2024 Extraordinary Healer® event

Retrieved on: 
Friday, April 5, 2024
Washington Convention Center, Congress, Caregiver, Walter, Patient, Research, News, Cancer, University, Woman, Survivor, Johnson & Johnson, Breast cancer, Immune system, Media Group, Multimedia, Vaccine, CURE, Young, PEP, Courage

This award honors oncology nurses whose compassion and expertise improve the lives of their patients.

Key Points: 
  • This award honors oncology nurses whose compassion and expertise improve the lives of their patients.
  • “We are honored to have Kristen Dahlgren as our keynote speaker for the 2024 Extraordinary Healer recognition program,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences®, the parent company of CURE.
  • For the first 30 years of her career, Dahlgren traveled the world where she actively worked on documenting some of the biggest news stories.
  • For more information on the 2024 Extraordinary Healer event and to register, please visit the event page .

Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International

Retrieved on: 
Thursday, April 4, 2024
Homocysteine, Homocystinuria, Caregiver, SAN, HCU, Society, Treatment, Therapy, Genetic, SIMD, Pharmaceutical industry

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present eight posters in classical homocystinuria (HCU) at Society for Inherited Metabolic Disorders (SIMD) in Charlotte, North Carolina from April 14-17, 2024, and Genetic Metabolic Dieticians International (GMDI) in Charlotte, North Carolina from April 17-20, 2024.

Key Points: 
  • SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present eight posters in classical homocystinuria (HCU) at Society for Inherited Metabolic Disorders (SIMD) in Charlotte, North Carolina from April 14-17, 2024, and Genetic Metabolic Dieticians International (GMDI) in Charlotte, North Carolina from April 17-20, 2024.
  • At SIMD and GMDI, the Company will present the trial design of the pivotal Phase 3 HARMONY Study of pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of classical HCU.
  • Additionally, the Company will share insights on the development of an innovative tool used for dietary management and monitoring in the Phase 3 HARMONY Study and open-label extension ENSEMBLE Study, and the positive results from cohort 6 in the placebo-controlled Phase 1/2 COMPOSE Study of pegtibatinase in classical HCU.
  • “Classical HCU is an isolating and devastating rare disorder with very limited treatment options, including adherence to highly restrictive diets, leaving patients and their caregivers with immense challenges,” said Jula Inrig, M.D., chief medical officer of Travere Therapeutics.

Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth

Retrieved on: 
Thursday, April 4, 2024
Well, Organization, Bone marrow, Development, Learning, NLB, Walking, MAM, Disease, Empathy, Caregiver, Education, Patient, Social media, Research, Running, Hope, Wall, IMF, Quality of life, Marketing, International Myeloma Foundation, Huge, PFS, Human

“From South Korea to Portugal, India to Poland, all myeloma communities spoke as one voice once more for Myeloma Action Month!

Key Points: 
  • “From South Korea to Portugal, India to Poland, all myeloma communities spoke as one voice once more for Myeloma Action Month!
  • Beyond the numbers, this year’s #MyelomaACTIONMonth global campaign created ripples through the power of each myeloma story shared.
  • These ripples converged to create a mighty wave of awareness for multiple myeloma across the globe.
  • Sessions included Myeloma 101 & Understanding Your Labs, Financial Considerations in Myeloma, and Symptom Management and Living Well with Myeloma and much more.

BridgingApps® to Curate Apps for Sentara Health Plans Members with Special Health Care Needs

Retrieved on: 
Wednesday, April 3, 2024
Diagnosis, Health, Smartphone, Database, Social, Caregiver, Patient, School, Hospital, Sentara Healthcare, Quality of life, Safety, Disability, Nursing

HOUSTON, April 03, 2024 (GLOBE NEWSWIRE) -- BridgingApps®, a program of Easter Seals Greater Houston, a 501(c)(3) non-profit organization, is partnering with Sentara Health Plans to provide expertly vetted lists of mobile device applications, or apps, to support its members who have special health care needs or disabilities.

Key Points: 
  • HOUSTON, April 03, 2024 (GLOBE NEWSWIRE) -- BridgingApps®, a program of Easter Seals Greater Houston, a 501(c)(3) non-profit organization, is partnering with Sentara Health Plans to provide expertly vetted lists of mobile device applications, or apps, to support its members who have special health care needs or disabilities.
  • Later this year, qualified Sentara Health Plans members will have access to a comprehensive list of curated apps recommended by BridgingApps Care Managers.
  • This will better equip members to manage their health decisions and develop important skill sets, ultimately improving their health and quality of life.
  • BridgingApps’ free App Search Tool, Search.BridgingApps.org , houses a database of apps trialed and reviewed by therapists, special education teachers, experts, and special needs users.

Greater Pittsburgh Festival of Books Releases Author Lineup, Opens Registration

Retrieved on: 
Wednesday, April 3, 2024
Storm, Carnegie library, Festival, HuffPost, Fordham University, Love, Acclamation, National Magazine Awards, Education Week, USA Today, The New York Times, English, Caregiver, Social justice, Barack Obama Academy, PBS, Black, Magic, Child, University, University of Pittsburgh, Teachers College, Columbia University, Perfect storm, Poetry, Diving, Carnegie Library of Pittsburgh, Catalog, Book, Death, KDKA, NPR, News Hour, Film industry

Pittsburgh, April 03, 2024 (GLOBE NEWSWIRE) -- Today, the Greater Pittsburgh Festival of Books announced registration is open for its third annual event, happening on May 11, 2024 on the campus of the Pittsburgh Theological Seminary in East Liberty.

Key Points: 
  • Pittsburgh, April 03, 2024 (GLOBE NEWSWIRE) -- Today, the Greater Pittsburgh Festival of Books announced registration is open for its third annual event, happening on May 11, 2024 on the campus of the Pittsburgh Theological Seminary in East Liberty.
  • Specially planned this year, the event will focus a portion of its programming on stories about Pittsburgh – and the greater Pittsburgh area – by hometown authors.
  • The Festival will be held from 10 a.m. to 5 p.m. on Saturday, May 11 at 616 North Highland Avenue, Pittsburgh.
  • The Festival is made possible thanks to support from sponsors including Carnegie Library of Pittsburgh, The Jack Buncher Foundation, KDKA and others.